James Huang
CIK: 0001573160
Transaction Breakdown
Open Market Buys (P)2 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Huang James
Huang James (SEC CIK 0001573160) files insider reports with the SEC as Director of Connect Biopharma Holdings Ltd (CNTB) and Director of CASI Pharmaceuticals, Inc. (CASI).
Signal8 holds 4 ownership filings by Huang James (2 Form 3, 2 Form 4), filed between Mar 18, 2026 and Jun 2, 2026. Those filings report 2 transactions, from Mar 31, 2026 to May 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Huang James's filings is in SINGAPORE.
Recent filings by Huang James
Other insiders filing for Connect Biopharma Holdings Ltd (CNTB)
- Xanthopoulos Kleanthis Gabriel, Director
- LIU JEAN I, Director
- Szekeres David Leslie, President
- Quart Barry D, Chief Executive Officer
- Peraza Lisa, Senior Vice President, Finance
- WILSON KAREN J, Director